[go: up one dir, main page]

JPS57185219A - Remedy for cancer - Google Patents

Remedy for cancer

Info

Publication number
JPS57185219A
JPS57185219A JP7022681A JP7022681A JPS57185219A JP S57185219 A JPS57185219 A JP S57185219A JP 7022681 A JP7022681 A JP 7022681A JP 7022681 A JP7022681 A JP 7022681A JP S57185219 A JPS57185219 A JP S57185219A
Authority
JP
Japan
Prior art keywords
cancer cells
cancer
activity
benzophenone derivative
cancer cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7022681A
Other languages
Japanese (ja)
Other versions
JPH0314807B2 (en
Inventor
Shinichi Kaiho
Koji Mizuno
Shunichi Hata
Masuo Koizumi
Narimitsu Honda
Yasushi Murakami
Shigeru Takanashi
Minoru Shindo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP7022681A priority Critical patent/JPS57185219A/en
Publication of JPS57185219A publication Critical patent/JPS57185219A/en
Publication of JPH0314807B2 publication Critical patent/JPH0314807B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: To provide the titled remedy containing a benzophenone derivative as an active component, and capable of eliminating the proliferation activity of cancer cell or eliminating the cancer cell itself by acting exclusively to cancer cells.
CONSTITUTION: The titled remedy contains the compound of formula (R1 and R2 are H, lower alkoxy, lower alkyl, or halogen; R3 is H, lower alkyl, or acyl) as an active component. Since the anticarcinomatous activity of an alkylation agent such as nitrogen mustard or an antimetabolite such as pyrine antagonist is non- selective, the agent attacks not only the cancer cells but also normal cells, and accordingly has high toxicity. On the contrary, the above benzophenone derivative attacks only the cancer cells, and eliminates its proliferation activity or eliminates the cancer cell itself. The activity of the benzophenone derivative is supposed as the redifferentiation of cancer cells produced by the abnormal differentiation of normal cells, i.e. elimination of cancer cells. It is administered orally or parenterally at a dose of usually 10mgW3g daily.
COPYRIGHT: (C)1982,JPO&Japio
JP7022681A 1981-05-12 1981-05-12 Remedy for cancer Granted JPS57185219A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7022681A JPS57185219A (en) 1981-05-12 1981-05-12 Remedy for cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7022681A JPS57185219A (en) 1981-05-12 1981-05-12 Remedy for cancer

Publications (2)

Publication Number Publication Date
JPS57185219A true JPS57185219A (en) 1982-11-15
JPH0314807B2 JPH0314807B2 (en) 1991-02-27

Family

ID=13425423

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7022681A Granted JPS57185219A (en) 1981-05-12 1981-05-12 Remedy for cancer

Country Status (1)

Country Link
JP (1) JPS57185219A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018606A1 (en) * 1994-01-06 1995-07-13 Research Development Foundation Curcumin, analogues of curcumin and novel uses thereof
WO2000042012A1 (en) * 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
EP1690853A1 (en) * 1999-01-13 2006-08-16 Bayer Pharmaceuticals Corporation W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
WO2012142698A1 (en) * 2011-04-20 2012-10-26 Universite Laval Alkylurea derivatives active against cancer cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEM.ABSTR=1979 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018606A1 (en) * 1994-01-06 1995-07-13 Research Development Foundation Curcumin, analogues of curcumin and novel uses thereof
WO2000042012A1 (en) * 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
EP1690853A1 (en) * 1999-01-13 2006-08-16 Bayer Pharmaceuticals Corporation W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
WO2012142698A1 (en) * 2011-04-20 2012-10-26 Universite Laval Alkylurea derivatives active against cancer cells

Also Published As

Publication number Publication date
JPH0314807B2 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
HU9500240D0 (en) New prolin-amide derivatives and pharmaceutical compositions containing them as active component
FI890689A0 (en) 3-ALKENYL-1-AZABICYCLO- / 3.2.0 / -HEPT-2-EN-2-CARBOXYLSYRAFOERENINGAR.
CA2257016A1 (en) Imidazolidin-4-one derivatives useful as anticancer agents
AU7484887A (en) Method for inhibiting aging
AU552322B2 (en) Substituted imidazoles
IE800327L (en) N-substituted aziridine-2-carboxylic acid derivatives
AU9095782A (en) 4 n-phenyl benzyl-aminomethyl-imidazole
JPS57185219A (en) Remedy for cancer
JPS55111420A (en) Antitumorigenic agent
DE3668888D1 (en) AN IMIDAZOLID INTRION DERIVATIVE OR A PHARMACEUTICAL COMPOSITION CONTAINING ITS PHARMACEUTICAL ACCEPTABLE SALTS.
ES8603406A1 (en) Acylindole derivatives and pharmaceutical compositions containing them.
GB9125970D0 (en) New compounds
JPS5424895A (en) Pyranochromone derivatives and remedies for allergic disorder
GB1409648A (en) Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof
CA2364446A1 (en) Novel immunosuppressive agent
HK1080282A1 (en) Improved formulations containing substituted imidazole derivatives
HK1029121A1 (en) Natural antitumor or antiviral substances and use of the same.
IE780262L (en) Carbocyclic fused thiophen-2-oxaminic acid derivatives
ES8502700A1 (en) Derivatives of tetrahydrobenzothiazole and herbicidal compositions containing the same as an active ingredient
JPS5395912A (en) New derivative of active acetic acid ulceratives
DK540589A (en) pyrrolidine
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
ES8304923A1 (en) New peptide, process for preparation thereof and pharmaceutical composition containing it.
JPS5746915A (en) Antiallergic agent
JPS5692260A (en) Cyclohexanecarboxylic ester and its preparation